Tag Archives: Karin Hehenberger

Karin Hehenberger: Paying The Gift Of Life Forward

The last time “06880” checked in with Karin Hehenberger, it was January 2021.

The Westporter – a native of Sweden who earned a Ph.D. there, did post-doctoral work at Harvard, then joined a hedge fund — had endured extremely tough times.

As a teenager she was diagnosed with Type 1 diabetes. Over the next 20 years Karin had eye problems. Her kidneys and pancreas failed. A pacemaker was installed in her heart.

Karin Hehenberger

Her father Michael — an IBM executive who had moved to Westport with his wife and Karin’s younger sister Anna, when she was in high school — donated a kidney. Karin’s eyes were treated with a product she’d worked on in her healthcare days. Her vision was saved; she did not dialysis.

On January 2, 2010, she got another gift: a pancreas transplant.

As she recovered, Karin thought about her career.

She had never connected with any other diabetic. “Patients need patients just as much as much as we need doctors,” she realized.

And, she says, “even though I was so involved with innovation and technology, I’d never allowed my own experience to be part of the assessment. I didn’t want to think I was biased.”

Gradually, Karin says, “I understood that patients can be innovators. We know the problems. We can have solutions.”

That set off a light bulb in her head. In 2014 she started Lyfebulb. The name combines that idea of innovation with the optimism of “life.” (The “Y” resembles a light bulb — and the logo colors are the same as Sweden’s.)

Lyfebulb’s mission is to “reduce the burden of living with chronic
disease through the power of the patient.”

Through digital solutions, innovation challenges, events, panel discussions, workshops, social media, newsletters and blogs, her company works with patients in 11 disease areas: transplantation, diabetes, cancer, multiple sclerosis, chronic kidney disease, IBD, migraine, substance use disorders, mental health, psoriasis and chronic cough.

Life was good. But 3 years ago, Karin’s kidney began to decline.

A combination of factors — COVID; the stress of her marriage breaking down; juggling work as an entrepreneur with the demands of single motherhood; the effects of immunosuppressive drugs — led to more medical issues.

 

Karin Hehenberger and her daughter.

She was always fatigued, and extremely sensitive to cold. She underwent several surgeries for skin cancer. She had dental abscesses, and a hip replacement.

Last summer Karin’s father asked her to speak to her middle sister, Lisa, who had previously offered to donate a kidney.

She quickly said yes. A business school professor in Barcelona, she arranged to take time off work, and for childcare.

However, a pre-surgery angiogram caused several complications for Karin. Her kidney function plummeted to 5%. She underwent 9 harrowing sessions of dialysis.

Through it all, Karin says, her support system – her family and many Westport friends — kicked in.

In 2009, Karin’s father had given her the gift of life. This past April, he sister did the same.

The transplant was successful. While Karin was still on the operating table, Lisa’s kidney began functioning in its new body.

“So what am I going to do with this gift?” Karin asks.

She answers her own question:

I will live every day to the fullest, which doesn’t mean I will do as much as I can every day, but I will measure myself and take care of my new ‘baby’ so that it can serve me as long as possible.

I will take care of my body by eating right, sleeping enough, exercising regularly and practicing mental health through meditation and mindfulness. I will be kind to myself when I feel tired, and I will be respectful to others and always keep in mind that the exterior of someone is not always a reflection of their inner self. I will cherish my friends who have stood by me through the hardship of kidney failure and dialysis.

I will continue to serve patients through my work. I will partner with great companies and leaders in academia to promote innovation. I will provide opportunities for my team to both grow professionally while also taking care of their families.

Above all, my life is dedicated to the family who saved me, and my own little family, whom I am raising with all of my heart. I appreciate each of my sisters, parents, brothers in law, nieces and nephews, and especially my daughter.

To my daughter, I want to show that life may not be a walk in the park – you need to fight for what you want – but it is beautiful. I want her to know that she will always be taken care of, and endlessly loved by, her Mamma.

Karin Hehenberger, shortly after her kidney transplant.

She’s also doing something else.

Karin is trying to raise awareness about the importance of organ donation: both asking, and offering. Close to 20 people on the transplant list die each day in the US, while waiting for a kidney.

“Many people are hesitant — or don’t have the courage — to ask family members to consider donating,” she says.

Both her father and sister underwent rigorous evaluations to ensure they’d be okay. Her sister recovered quickly. And — 14 years after donating his own kidney — her 78-year-old father is now at the K2 base camp, reading to climb that challenging mountain.

She knows she is lucky. Both her father and sister could take time off work to help. Karin understands that many relatives do not have that luxury. And in some minority communities there is skepticism toward healthcare, along with high incidences of diseases like hypertension and diabetes that limit the pool of potential donors.

Karin also advocates for research into better post-transplant drugs (they cause severe side effects like infections and cancer; in her case, they caused scarring in her transplanted kidney that led to its eventual failure).

She is also addressing gaps in the healthcare system, which forces transplant patients to navigate long-term — on their own — the drugs they take, the preventative and therapeutic visits to specialists needed, and their mental health.

Karin’s Lyfebulb platform will continue to connect people, inspire change and impact lives. The transplant page, connecting recipients, care partners, donors, donor families and transplantation experts, is particularly active.

Or, you could say, filled with new life.

(“06880” proudly features inspiring stories about amazing Westporters. Please click here to support our work. Thank you!)

 

Lyfebulb: “Aha!” Idea For Managing Chronic Disease

Karin Hehenberger has led a lucky life.

She grew up in Sweden, graduated from an international high school in Paris, attended medical school and earned her Ph.D. in Stockholm, and did post-doctoral work at Harvard.

Karin Hehenberger

In Cambridge she became friendly with Business School students. At 26 she was hired by McKinsey as a healthcare consultant. Then it was off to Wall Street, to work for a hedge fund.

But Karin’s life has been filled with bad luck too.

In her teens she was diagnosed with Type 1 diabetes. She kept it secret from everyone except her family. If others knew, she thought, they’d view her as “weak.”

Over the next 20 years, she suffered complications. Diabetes affected her eyes; her kidneys and pancreas were failing, and she had a pacemaker. “I was a walking stroke risk,” Karin says.

Her father Michael — an IBM executive who had moved to Westport with his wife and Karin’s younger sister Anna, when she was in high school — donated a kidney. Karin’s eyes were treated with a product she’d worked on in her healthcare days. Her vision was saved; she did not dialysis.

She also made the list for a pancreas transplant. On New Years Eve 2009, she got a call: Get to Minneapolis immediately. A second pancreas was available.

But it was damaged in transit. “Frozen and dejected,” Karin says, she got ready for the new year.

Providentially, almost immediately she got another call. Another pancreas was on the way.

Karin Hehenberger, after her pancreas transplant.

On January 2, 2010, Karin’s life changed. She has not injected insulin since. She’d performed that life-saving ritual 5 to 10 times a day — and spent many more hours checking her blood sugar.

As she recovered, Karin thought about her career.

She had never connected with any other diabetic. “Patients need patients just as much as much as we need doctors,” she realized.

And, she says, “even though I was so involved with innovation and technology, I’d never allowed my own experience to be part of the assessment. I didn’t want to think I was biased.”

Gradually, Karin says, “I understood that patients can be innovators. We know the problems. We can have solutions.”

That set off a light bulb in her head. In 2014 she started Lyfebulb. The name combines that idea of innovation with the optimism of “life.” (The “Y” resembles a light bulb — and the logo colors are the same as Sweden’s.)

Lyfebulb’s mission is to “reduce the burden of living with chronic
disease through the power of the patient.”

Karin started out thinking only of her experience as a transplant recipient. “It’s very complex to be alive because someone else died, or gave up a part of themselves,” she explains. “But we were all alone. I thought there needed to be a community of transplant patients.”

As she tried to find ways to empower people with transplants — “not just to take charge of their lives, but to be valued and respected” — she realized there were commonalities with people suffering from chronic diseases who did have “communities” (for example, cancer patients and those with inflammatory bowel disease).

Through digital solutions, innovation challenges, events, panel discussions, workshops, social media, newsletters and blogs, her company works with patients in 11 disease areas: transplantation, diabetes, cancer, multiple sclerosis, chronic kidney disease, IBD, migraine, substance use disorders, mental health, psoriasis and chronic cough.

Karin Hehenberger and her daughter, in Westport.

Lyfebulb — which, since COVID, Karin has run out of her Westport home — is a for-profit company. It pays patients for their insights, and uses their ideas to build products for the marketplace.

For example, a young diabetic realized he did not always remember the last time he dosed himself.

“It’s not easy to keep track of,” Karin notes. “You’re making 300 decisions a day related to food, checking blood sugar and insulin.”

The simple solution: a pen cap that allows people to record the time and amount of each dose.

“Diabetics want to live without thinking about their disease,” Karin says. “Doctors want them to test constantly, to optimize glucose control. Those two things completely contradict each other.”

But without seeking patients’ input and insights, no company would think to manufacture an insulin pen cap like that. Three now do.

Similarly, Karin says, Lyfebulb learned that diabetics wanted an insulin device that’s less bulky and institutional-looking than the standard gray ones. Nothing stopped that — except no one ever asked.

“That’s a consumer insight,” she notes. “In every other field, consumers drive product development. In healthcare, consumer marketing has always been an afterthought.”

Karin’s goal is for Lyfebulb to “replace Facebook for health information.” On the ubiquitous social media platform, she says, “there’s no moderation. Anyone can say anything about a product or remedy. It’s not safe.”

Karin’s goal is for Lyfebulb to “replace Facebook for health information.” On the ubiquitous social media platform, she says, “there’s no moderation. Anyone can say anything about a product or remedy. It’s not safe.”

This month, Lyfebulb launched TransplantLyfe, an online engagement platform for the transplant community.

Lyfebulb ensures scientific and medical reviews. “We want to harness the power of a crowd to change the way people deal with chronic disease. We take over when doctors and nurses leave,” Karin says.

“You’re not alone. You’re not different,” she says to people living with chronic diseases. “You can be helped by people just like you.”